The UNC Lineberger Comprehensive Cancer Center is one of the leading cancer centers in the nation, pioneering critical research to treat patients and find cures. One of the many promising treatments that UNC Lineberger is researching is CAR-T immunotherapy - a novel method personalized to individual patients. This process involves extracting a patient’s immune cells and genetically engineering them to destroy the patient's own cancer cells.
To learn more about UNC Lineberger's CAR-T immunotherapy research, visit the link the below:

UNC Lineberger is filled with talented experts and researchers. Among them is Dr. Ian Davis -  the Co-leader of the Cancer Genetics Program at UNC Lineberger. Dr. Davis is also the G. Denman Hammond Professor of Childhood Cancer and Chief of the Division of Pediatric Hematology-Oncology at UNC-Chapel Hill, where his lab has had a primary focus on Ewing sarcoma and other solid tumors.

At the TNT Strong Foundation, our goal is to help power the next generation of life-saving research. That’s why we aim to partner with institutions like the UNC Lineberger Comprehensive Cancer Center and researchers like Dr. Ian Davis to fund transformational research.